Citation

Kawoos Y, Shah IA, Rather YH, Wani ZA, Zarger WA. J. Clin. Diagn. Res. 2018; 12(4): VC10-VC14.

Copyright

(Copyright © 2018, JCDR Prepublishing)

DOI

10.7860/JCDR/2018/31410.11446

PMID

unavailable

Abstract

INTRODUCTION: Electroconvulsive Therapy (ECT) is one of the neurobiological therapies available for the treatment of various psychiatric disorders especially those resistant to pharmacotherapy or, where a rapid response is needed.

AIM: To study the response of patients with different psychiatric disorders to ECT and study the relationship between seizure duration and response.

MATERIALS AND METHODS: It was a longitudinal study where a total of 40 patients were studied. Patients aged ≥12 years, who were resistant to pharmacotherapy or, having conditions where rapid response was warranted like suicidality or catatonia were included in our study as cases. A written informed consent was taken from all patients or their caretakers wherever necessary. Scales for assessment of various disorders were applied before and after treatment.

RESULTS: Majority of the patients 37.5% were in the age-group of 38-47 years followed by 22.5% in 28-37 years. Only 5% of patients were aged >60 years. Males were slightly higher in number as compared to females (21:19). Affective disorders formed the major group of the patients (75%) followed by schizophrenia (10%), obsessive compulsive disorder (10%) and mental retardation (5%). Overall, 75% of patients showed >50% response to ECT with maximum response seen in affective disorders. No significant relation was seen between seizure duration and response to ECT.

CONCLUSION: ECT is very effective for treating various psychiatric disorders especially affective disorders. ECT is life saving in conditions like catatonia and suicidality. © 2018, Journal of Clinical and Diagnostic Research. All rights reserved.

Language: en

Keywords

adult; human; female; male; aged; bipolar disorder; Suicidality; schizophrenia; major depression; lithium; suicidal behavior; bipolar depression; disease severity; longitudinal study; pain; mental disease; clinical article; headache; middle aged; electroconvulsive therapy; paracetamol; confusion; seizure; follow up; demography; Response; delirium; mental deficiency; catatonia; mania; amnesia; agitation; midazolam; obsessive compulsive disorder; Affective disorders; disease duration; treatment response; Montgomery Asberg Depression Rating Scale; Article; clinical effectiveness; treatment duration; Clinical Global Impression scale; Young Mania Rating Scale; therapy resistance; young adult; Yale Brown Obsessive Compulsive Scale; treatment resistant depression; Becks Suicide Intent Scale; Bush Francis Catatonia Rating Scale; Montgomery asberg depression rating scale; Yale-brown obsessive compulsive scale